• Capricor Therapeutics (CAPR) Stock Rating Lowered by Zacks Investment Research

    Capricor Therapeutics (NASDAQ:CAPR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on …

    Read More
  • 0 0